Lars Ekman

CIK 1376117 · last filed 2026-05-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$458.1K

Companies

6

Total Filings

71

Lifetime Open-Market Net

-$15.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRTA Director 3,148 $8.25 $26.0K -$7.55M 20 2026-05-15
AMRN Director 0 $15.24 $0 -$7.47M 17 2022-06-29
RARE Director 17,745 $24.35 $432.1K $0 8 2022-06-28
Spark Therapeutics, Inc. (ONCE) Delisted Director 0 $0 5 2019-12-17
SOPHIRIS BIO INC. (SPHS) Delisted Director 520 -$4.5K 7 2019-06-28
ARYx Therapeutics, Inc. (ARYX) Delisted Director $0 3 2010-05-03

Recent Filings · Page 2 of 8

71 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-28 RARE Grant (A) +3,300 $0 EDGAR
2022-05-27 PRTA Grant (A) $0 EDGAR
2021-06-28 RARE Grant (A) +2,145 $0 EDGAR
2021-06-16 AMRN Grant (A) $0 EDGAR
2021-05-21 PRTA Grant (A) $0 EDGAR
2021-02-17 PRTA Mixed $0 EDGAR
2020-07-15 AMRN Grant (A) $0 EDGAR
2020-06-30 RARE Grant (A) +2,550 $0 EDGAR
2020-05-22 PRTA Grant (A) $0 EDGAR
2019-12-17 Spark Therapeutics, Inc. (ONCE) Delisted Mixed −3,000 -$343.5K EDGAR
Showing 1120 of 71
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.